title: Safety of tiotropium through the Handihaler: why did meta-analyses and database studies appear to give a false alarm?
authors.affiliation: Respiratory Medical Franchise, GSK, Uxbridge, UK The William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, UK.
authors.forename: Neil C
authors.initials: NC
authors.lastname: Barnes
authors.affiliation: St George's University of London, London, UK.
authors.forename: Paul W
authors.initials: PW
authors.lastname: Jones
authors.affiliation: GSK, Worldwide Epidemiology, Wavre, Belgium.
authors.forename: Kourtney J
authors.initials: KJ
authors.lastname: Davis
mesh_terms: D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D015201:Meta-Analysis as Topic; D018727:Muscarinic Antagonists / Q000009:adverse effects; D009330:Nebulizers and Vaporizers; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy; D016032:Randomized Controlled Trials as Topic; D012196:Review Literature as Topic; D012602:Scopolamine Derivatives / Q000008:administration & dosage / Q000009:adverse effects*; D000069447:Tiotropium Bromide
chemical_list: D001993:Bronchodilator Agents; D018727:Muscarinic Antagonists; D012602:Scopolamine Derivatives; D000069447:Tiotropium Bromide
keywords: COPD Pharmacology; Inhaler Devices